Our goal is to advance the development and delivery of healthcare products through testing, development and manufacturing services in partnership with clients worldwide.

Founded in 1947 as Microbiological Associates, BioReliance is the largest provider of outsourcing services focused on the rapidly growing biologics sector of the pharmaceutical industry. BioReliance has provided services to over 600 clients annually, including most of the largest pharmaceutical and biopharmaceutical companies in the world. For established biotechnology and pharmaceutical companies, outsourcing to BioReliance streamlines product development and reduces time to market. The Company also supports early stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance's services and broad experience provide all of its clients with a cost-effective alternative to the fixed costs associated with internal biologics development and manufacture.

All of our studies are conducted in total confidence and we comply with the latest recommendations from the FDA, ICH, CPMP, and Japanese Ministry of Health and Welfare. All assays are performed under full compliance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards.

We have formed strong partnerships with many of the world’s leading biopharmaceutical and biotechnology firms; many biologicals now licensed by the FDA, EMEA and other international agencies have been tested and validated by BioReliance.